If they actually do what they say there, we could see revenue for the first time this year, instead 5-10 years away (short of a buy out, or partner). With the US crack down on pain killer opiates, all the bleeding disorder issues with NASIDs this could become a dynamite product, new OTC pain killer, if they get major volume distribution.
Anyone know what the prior CEO, major stock holder is doing and why he named a new CEO? Is he still the COB? He is the single largest shareholder, way over 50% owner last time I checked.